93 related articles for article (PubMed ID: 7864195)
1. Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy.
Weiss HR; Rodriguez E; Tse J
Am J Physiol; 1995 Feb; 268(2 Pt 2):H686-91. PubMed ID: 7864195
[TBL] [Abstract][Full Text] [Related]
2. Myocardial metabolic and functional responses to acetylcholine are altered in thyroxine-induced cardiac hypertrophy.
Weiss HR; Tse J
Can J Physiol Pharmacol; 1995 Jun; 73(6):729-35. PubMed ID: 7585345
[TBL] [Abstract][Full Text] [Related]
3. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
[TBL] [Abstract][Full Text] [Related]
4. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
[TBL] [Abstract][Full Text] [Related]
5. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
Straznicka M; Leone RJ; Scholz PM; Weiss HR
J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
[TBL] [Abstract][Full Text] [Related]
6. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
[TBL] [Abstract][Full Text] [Related]
7. cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
Straznicka M; Gong G; Tse J; Scholz PM; Weiss HR
Am J Physiol; 1997 Oct; 273(4):H1949-55. PubMed ID: 9362265
[TBL] [Abstract][Full Text] [Related]
8. Basal muscarinic activity does not impede beta-adrenergic activation in rabbit hearts in controls or thyroxine-induced cardiac hypertrophy.
Naim KL; Rabindranauth P; Scholz PM; Tse J; Weiss HR
J Cardiovasc Pharmacol; 1997 Oct; 30(4):405-11. PubMed ID: 9335397
[TBL] [Abstract][Full Text] [Related]
9. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
Katz E; Zhang Q; Weiss HR; Scholz PM
Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
[TBL] [Abstract][Full Text] [Related]
10. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase.
Lazar MJ; Patel K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2001 Oct; 38(4):512-9. PubMed ID: 11588521
[TBL] [Abstract][Full Text] [Related]
11. Propranolol and thyroxine-induced hypertrophic rabbit hearts: effect on heart size and regional O2 supply/consumption variables.
Grover GJ; Houghton JM; Weiss HR
Basic Res Cardiol; 1988; 83(3):268-76. PubMed ID: 2970840
[TBL] [Abstract][Full Text] [Related]
12. Ageing blunts the effects of nitric oxide on myocardial O2 consumption.
Weiss HR; Lazar MJ; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):924-30. PubMed ID: 12207573
[TBL] [Abstract][Full Text] [Related]
13. Effect of T4-induced cardiac hypertrophy on O2 supply-consumption balance during normoxia and hypoxia.
Talafih K; Grover GJ; Weiss HR
Am J Physiol; 1984 Mar; 246(3 Pt 2):H374-9. PubMed ID: 6230939
[TBL] [Abstract][Full Text] [Related]
14. Increased O2 consumption and positive inotropy caused by cyclic GMP reduction are not altered after L-type calcium channel blockade.
Leone RJ; Naim KL; Scholz PM; Weiss HR
Pharmacology; 1998 Jan; 56(1):37-45. PubMed ID: 9467186
[TBL] [Abstract][Full Text] [Related]
15. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy.
Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM
J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596
[TBL] [Abstract][Full Text] [Related]
16. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
Weiss HR; Rodriguez E; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts.
Leone RJ; Straznicka M; Scholz PM; Weiss HR
Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543
[TBL] [Abstract][Full Text] [Related]
18. Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning.
Patel KN; Weiss HR; Scholz PM
J Surg Res; 2000 Jul; 92(1):114-9. PubMed ID: 10864491
[TBL] [Abstract][Full Text] [Related]
19. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
20. Effect of nitroprusside on regional cerebral cyclic GMP, blood flow and O2 consumption in rat.
Lu X; Wei HM; Yospin J; Weiss HR
Brain Res; 1995 Jan; 669(1):35-40. PubMed ID: 7712162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
